NY-NMS-CAPITAL/LBN
4.2.2022 12:02:11 CET | Business Wire | Press release
DirectMed Parts & Service (“DirectMed”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired LBN Medical (“LBN” or the “Company”). Terms of the transaction were not disclosed.
Headquartered in Aalborg, Denmark, LBN is a leading reseller of aftermarket diagnostic imaging equipment to customers around the world. LBN sells complete systems and parts covering more than fifteen brands, including major OEMs such as Canon, GE, Hologic, Siemens, and Philips. The Company was founded in 2003 by CEO Lars Braun Nielsen and has since grown to more than 50 employees at facilities in Denmark and Egypt.
Lars Braun Nielsen, CEO and Founder of LBN, stated, “Brad and the DirectMed team have outlined their mission to extend the life of medical imaging equipment to improve access, reduce waste, and lower healthcare costs. We are thrilled to be a part of this endeavor, and to work with the DirectMed team and NMS to accelerate our growth. The partnership with DirectMed provides LBN with tremendous resources to provide an even higher level of service and expertise to our customers, including a greater breadth and depth of parts and technical support.”
“We have known LBN Medical for several years and believe they are the logical company to help DirectMed expand our parts business outside of North America. Their distribution team – which speaks 21 different languages, with sales history in over 60 countries, and employs experts across seven modalities – is the perfect complement to our business,” said Brad de Koning, DirectMed’s President & CEO. “Acquiring LBN Medical begins an exciting new chapter for DirectMed, with the addition of system sales to our customer base, and for LBN Medical, who will now stock and have access to over 10,000 unique part numbers to support theirs.”
David Peterson, Managing Director at NMS, stated, “Since we partnered with the DirectMed team in June 2021, one of our primary areas of focus has been expanding our geographic coverage. Providers around the world are looking for cost-effective solutions to acquire and maintain equipment as they continue to grow their practice. The combination of DirectMed and LBN supports that exact need in the marketplace. We are very excited to be partnering with the LBN team for the next phase of our business and look forward to leveraging DirectMed’s experience in parts and related repairs to accelerate our growth internationally.”
Accura and Greenberg Traurig provided legal advice to DirectMed.
About LBN:
LBN Medical is a leading reseller of aftermarket medical imaging equipment to customers around the world. LBN sells equipment and parts covering more than fifteen brands, including major OEMs such as Canon, GE, Siemens, and Philips. The Company was founded in 2003 by CEO Lars Braun Nielsen, and has since grown to an organization of more than 50 associates at facilities in Denmark and Egypt. For additional information on LBN, please visit the firm's website at LBNmedical.com
.
About DirectMed:
DirectMed Parts & Service is the largest independent diagnostic imaging parts supplier specializing in MRI and CT machines with over 60,000 parts in stock. An ISO 13485 certified company, DirectMed repairs, supports and sells GE, Siemens, and Philips parts to healthcare networks, imaging centers and independent service organizations ("ISOs") around the world. For additional information on DirectMed, please visit the firm's website at directmedparts.com
.
About NMS Capital:
NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The firm was formed through the spin-out of a group of portfolio companies from Goldman Sachs’ Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Business Services and Healthcare Services. For additional information on NMS, please visit the firm's website at nms-capital.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220204005064/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Named a Leader in Five 2026 IDC MarketScapes for Worldwide Supply Chain Planning13.11.2026 13:00:00 CET | Press release
Maestro delivers concurrent planning on a single platform across discrete, process, consumer packaged goods and life sciences Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced it has been named a Leader in five 2026 IDC MarketScape vendor assessments for worldwide supply chain planning. The recognition spans the overall market and four industries - discrete industries, process industries, consumer packaged goods and life sciences industries - all served by a single platform, Kinaxis Maestro®, the company's AI-powered supply chain orchestration platform. "Supply chain leaders don't need a better forecast once a month. They need to know what changed this morning, what it means across the business, and what to do about it," said Andrew Bell, Chief Product Officer of Kinaxis. "I believe being named a Leader across five IDC MarketScape vendor assessments, in industries that plan in very different ways, shows that a single concurr
SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics to Advance Clinic Profitability Through Medical AI13.11.2026 12:30:00 CET | Press release
Companies to co-develop six medical AI solutions targeting revenue expansion and cost reduction; SBC Medical secures priority sales rights in Japan and South Korea and targets B2B expansion across Asia SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced a strategic capital and business alliance agreement with NeuroBrain Dynamics Inc. (“NBD”), a Taipei-based company dedicated to enterprise generative AI solutions. As part of the agreement executed on November 13, 2026, SBC Medical has made a minority equity investment in NBD. Through this alliance, SBC Medical plans to introduce two complementary suites of generative AI solutions across its network of 287 clinics in Japan and overseas*: “revenue-growth AI,” to elevate average revenue per visit and customer retention through personalized customer guidance, and “cost-reduction AI,
SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results13.11.2026 12:30:00 CET | Press release
Revenue Up 35%, Net Income Attributable to SBC Medical Up 22%, and Adjusted EBITDA1 Up 66% Year-over-Year; Net Income Margin of 27% and Adjusted EBITDA Margin of 47% — Previously Announced Service Fee Revisions and New Clinic Openings Contribute to Revenue Growth and Operating Margin Improvement SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields to medical institutions in Japan and abroad, today announced its consolidated financial results for the third quarter of fiscal year 2026 (the three months ended September 30, 2026) and the three cumulative quarters of fiscal year 2026 (the nine months ended September 30, 2026). Third Quarter 2026 Financial Highlights Total revenues were $59 million, up 35% year-over-year. Income from operations was $26 million, up 66% year-over-year, with an operating margin of 45%. Net income attributable to SBC Medi
Interactive Brokers Offers Eligible Clients Access to the Anthropic, PBC Initial Public Offering13.11.2026 11:00:00 CET | Press release
ADVERTISEMENT This advertisement constitutes an advertisement within the meaning of the Prospectus Regulation and marketing communication within the meaning of MiFID II and is prepared by and in the sole responsibility of Interactive Brokers Ireland Limited, North Dock One, 91/92 North Wall Quay, Dublin 1, D01 H7V7, Ireland, a firm authorized and regulated by the Central Bank of Ireland. Eligible clients of Interactive Brokers Ireland Limited can participate in the offering. Interactive Brokers Ireland Limited, part of Interactive Brokers Group (Nasdaq: IBKR), an automated global broker, today announced that eligible clients can participate in the initial public offering (the “Offering”) of Anthropic, PBC (the “Company”). Through the IBKR platform, eligible clients resident and located in Denmark, Finland, France, Germany, Ireland, the Netherlands, Norway, Spain, and Sweden can review the Offering and submit an application during the offer period, which is open for all eligible clients
Yamaha to Acquire Disguise, Expanding Its Capabilities in Integrated Audio, Video, Lighting and Media13.11.2026 08:00:00 CET | Press release
Acquisition combines Yamaha’s audio expertise with Disguise’s software and media server technologies Yamaha Corporation today announced an agreement to acquire Disguise Technologies Limited (“Disguise”), a London-based provider of software and media server technologies for live and immersive experiences. Yamaha will acquire the company by purchasing all shares in its parent, Butterfly Topco Limited. The acquisition will expand Yamaha’s capabilities beyond audio into integrated audio, video, lighting and media solutions, in line with its strategy to expand beyond hardware into software and services. By combining Yamaha’s audio expertise and global reach with Disguise’s software, technologies and worldwide partner network, the companies will be better positioned to deliver immersive experiences across live entertainment, sports and other venues. Disguise’s technology powers live and immersive experiences worldwide, including tours by Beyoncé and Taylor Swift and venues such as New York’s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
